纤维化间质性肺病患者体重减轻的专科饮食干预:一项先导性随机对照试验
该先导性随机对照试验纳入纤维化间质性肺病伴低体重或体重减轻的患者,1:1随机分为12周专科饮食干预组或饮食信息表对照组,主要评估招募、随机化和保留的可行性。共筛查128例,随机化40例(31%),全部完成研究;饮食组42%的患者12周体重增加≥1 kg,对照组仅4.8%(OR 14.2,95%CI 1.4-141.8,P=0.02)。
要点
- F-ILD伴体重减轻患者随机接受12周专科饮食干预可行,7个月内达到目标样本量。
- 饮食组12周体重增加≥1 kg的比例显著高于对照组(42% vs 4.8%)。
- 4-12周体重变化速率饮食组为+0.40 kg/月,对照组为-0.25 kg/月,差异利于饮食组。
核心结论
- 在F-ILD伴体重减轻患者中开展专科饮食干预的随机对照试验是可行的。
- 先导试验结果鼓励进一步开展确定性多中心随机对照试验。
研究设计与样本
- 先导性随机对照试验,F-ILD伴低体重或体重减轻患者按1:1随机分为12周专科饮食干预组或饮食信息表对照组。
- 采用计算机生成序列随机分组,随机区组设计,并按抗纤维化药物分层。
- 共筛查128例患者,随机化40例(31%),饮食组19例,对照组21例。
主要发现
- 饮食组12周体重增加≥1 kg者为8/19(42%),对照组为1/21(4.8%)(OR 14.2;95%CI 1.4-141.8;P=0.02)。
- 经过4周滞后,4至12周估计体重变化速率对照组为-0.25 kg/月(95%CI -0.61至0.12),饮食组为+0.40 kg/月(95%CI 0.02至0.78)。
- 所有随机化患者均完成研究,目标患者数在7个月内达到。
临床怎么用
- 对F-ILD伴低体重或体重减轻的患者,可考虑转介专科饮食干预以改善体重。
- 该先导试验支持开展更大规模多中心随机对照试验验证饮食干预效果。
局限性
- 本研究为先导性试验,样本量小(共40例随机化),结果需在确定性试验中验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Weight loss in patients with fibrotic interstitial lung disease (F-ILD) is associated with poor prognosis, yet the impact of dietary input is unknown. RESEARCH QUESTION: What is the feasibility of a randomized controlled trial of specialist dietary intervention in F-ILD? STUDY DESIGN AND METHODS: Patients with F-ILD experiencing low weight or weight loss were randomized 1:1 to either a 12-week specialist dietary intervention or a dietary information sheet by computer-generated sequence using random block design with stratification by antifibrotic drugs. The primary outcome was feasibility of recruitment, randomization, and retention. A key predefined exploratory outcome was weight change from baseline. RESULTS: Of 128 screened patients, 40 patients (31%) were randomized, 19 to diet and 21 to control arm. The target number of patients was reached within 7 months, suggesting feasibility of a larger trial. All randomized patients completed the study. In the diet arm, 8 of 19 (42%) vs 1 of 21 (4.8%) participants in the control arm gained ≥ 1 kg at 12 weeks (OR, 14.2; 95% CI, 1.4-141.8; P = .02). Analysis of the exploratory outcome of weight change revealed that after a 4-week lag, the estimated rate of weight change between 4 and 12 weeks was -0.25 kg/month (95% CI, -0.61 to 0.12) in the control and +0.40 kg/month (95% CI, 0.02 to 0.78) in the diet group, with a difference of +0.65 kg/month (95% CI, 0.15 to 1.14) in favor of the diet group (P = .01). INTERPRETATION: Based on the encouraging results of this pilot trial of dietary intervention in F-ILD, a definitive multicenter randomized controlled trial is warranted. CLINICAL TRIAL REGISTRATION: ClinicalTrials.gov; No.: NCT06016959; URL: www. CLINICALTRIALS: gov).
引用
- Kahai R, Castelli G, Danzo F, et al. Specialist Dietary Intervention in Patients With Fibrotic Interstitial Lung Disease Experiencing Unintentional Weight Loss: A Pilot Randomized Controlled Trial. Chest. 2025. PMID: 41015200. doi:10.1016/j.chest.2025.09.021
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。